{"doi":"10.1371/journal.pgph.0004466","title":"Cost and cost-effectiveness of pediatric home-based versus facility-based TB Preventive Treatment in Ethiopia (CHIP-TB)","abstract":"Tuberculosis preventive treatment (TPT) is an essential intervention recommended for all child contacts in Ethiopia under 15 years who are at risk of tuberculosis (TB) infection. We conducted a cost and cost-effectiveness analysis of home-based versus facility-based TPT provision for child contacts in Ethiopia. As part of the CHIP TB trial, a pragmatic, cluster-randomized trial conducted at eighteen clinics in Ethiopia, clinics were randomized to either a home-based model (intervention arm), administered by community health workers, or a facility-based model (standard of care) for managing child contacts. Cost data were collected from both a health service perspective and a household perspective, capturing all costs relevant to TPT. Costs were evaluated on a per-household basis, with the primary outcome being the difference in median costs per household initiating TPT. A secondary outcome assessed the cost-effectiveness as the incremental cost per additional child contact starting TPT. Probabilistic sensitivity analyses (PSA) were conducted to examine the robustness of findings. At an average cost of US$18.92 per household managed, Home-based contact management, including TPT delivery was cost-saving compared to facility-based TPT delivery (US$27.24 per household managed) assessed based on the partial-societal perspectives, largely due to reductions in household out-of-pocket costs. The home-based strategy was both less costly and had increased TPT initiation in 61.5% of the scenarios assessed in the PSA. Home-based contact management is a cost-saving alternative for households and provides comparable initiation rates to facility-based care, making it a feasible approach to improve TB preventive treatment accessibility. Although it does not entirely replace facility-based care, a hybrid model that respects household preferences and allows flexibility in delivery could enhance TB care access for socio-economically disadvantaged households, potentially reducing health inequities. The trial was registered on clinicaltrials.gov NCT04369326 on April 30, 2020. https://clinicaltrials.gov/study/NCT04369326.","journal":"PLOS Global Public Health","year":2025,"id":550559,"datarank":0.18147504117300894,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.016683197872792502,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.016683197872792502,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":2,"citers_with_citation_signal":1,"citers_with_endowment":1,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9498,"is_data_producer":true,"deposit_databanks":{"ClinicalTrials.gov":["NCT04369326"]},"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1111166,"name":"Ahmed Bedru","orcid":null,"position":1,"is_corresponding":false},{"id":1111162,"name":"Fiseha Mulatu","orcid":null,"position":2,"is_corresponding":false},{"id":286357,"name":"Bareng A. S. Nonyane","orcid":"0000-0001-5633-7487","position":3,"is_corresponding":false},{"id":1111164,"name":"Silvia Cohn","orcid":null,"position":4,"is_corresponding":false},{"id":902088,"name":"Christiaan Mulder","orcid":"0000-0003-2628-7460","position":5,"is_corresponding":false},{"id":930206,"name":"Samuel Bayu","orcid":null,"position":6,"is_corresponding":false},{"id":1446143,"name":"Stephanie Borsboom","orcid":null,"position":7,"is_corresponding":false},{"id":1446144,"name":"Gidea Conradie","orcid":null,"position":8,"is_corresponding":false},{"id":378803,"name":"Jonathan E. Golub","orcid":"0000-0003-2398-3145","position":9,"is_corresponding":false},{"id":346887,"name":"Richard E. Chaisson","orcid":"0000-0003-4710-925X","position":10,"is_corresponding":false},{"id":432140,"name":"Gavin Churchyard","orcid":"0000-0002-4269-3699","position":11,"is_corresponding":false},{"id":315468,"name":"David W. Dowdy","orcid":"0000-0003-0481-7475","position":12,"is_corresponding":false},{"id":893881,"name":"Hojoon Sohn","orcid":"0000-0001-5837-3844","position":13,"is_corresponding":false},{"id":447776,"name":"Nicole Salazar‐Austin","orcid":"0000-0002-9875-9319","position":14,"is_corresponding":false},{"id":772970,"name":"Akash Malhotra","orcid":"0000-0002-9298-0936","position":0,"is_corresponding":true}],"reference_count":14,"raw_metadata":null,"created_at":"2026-07-19T02:54:16.596730Z","pmid":"40305495","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}